Thyroid hormone (T3) regulates growth and differentiation during development and modulates the activity of a wide variety of metabolic pathways in adults. Disorders that result in low (hypothyroid) or high (hyperthyroid) levels of T3 are common, and result in a multitude of clinical effects owing to the broad distribution of T3 receptors. Thyroid hormone receptors (TRs) function as transcription factors to increase or decrease levels of gene expression. Although there has been great progress in our understanding of how T3 stimulates gene transcription, the mechanism by which it turns genes off is not well- understood. The physiologic role of negative regulation by T3 is most clearly illustrated by a classical negative feedback loop in which T3 inhibits the production of pituitary thyroid-stimulating hormone (TSH). The inhibition TSH by T3 represents a critical ~set-point~ that establishes the metabolic status of an individual. In this proposal, we will continue our studies of the TSH alpha and beta genes as a model for how T3 turns off gene transcription. Recent studies have identified a family of transcriptional co-repressors and co-activators that interact with the TR. We propose that these transcriptional co- factors play a critical role in T3 mediated repression. In the case of negatively regulated genes, we hypothesize that in the absence of T3, the unliganded TR recruits co-repressors away from the promoter resulting in transcriptional activation . Upon T3 binding to the receptor, a cascade of events is proposed to culminate in T3-dependent repression. These events include the displacement of co-repressors from TR to other proteins on the target promoter, and the ability of the activated TR to bind key co-investigate the role of Nuclear Co- repressors (NcoRs) in the control of genes that are repressed in response to T3; 2) To examine the interactions of transcriptional co- factors with the CREB/CBP transcription factors as a mechanism for T3-induced repression. These studies will address a fundamental question of how T3 acts as a switch to turn off a selected array of genes. In addition to the implications for thyroid hormone action, analogous mechanisms are likely to occur for other nuclear receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042144-10
Application #
2900221
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1990-12-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Nguyen, Lynda Q; Arseven, Onur Karamanoglu; Gerber, Hans et al. (2002) Cloning of the cat TSH receptor and evidence against an autoimmune etiology of feline hyperthyroidism. Endocrinology 143:395-402
Furlanetto, T W; Kopp, P; Peccin, S et al. (2000) A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate. Mol Genet Metab 71:520-6
Nogueira, C R; Nguyen, L Q; Coelho-Neto, J R et al. (1999) Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasia. Thyroid 9:523-9
Chien, P Y; Ito, M; Park, Y et al. (1999) A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. Mol Endocrinol 13:2122-36
Tagami, T; Park, Y; Jameson, J L (1999) Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. J Biol Chem 274:22345-53
Nogueira, C R; Kopp, P; Arseven, O K et al. (1999) Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid 9:1063-8
Tagami, T; Lutz, W H; Kumar, R et al. (1998) The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 253:358-63
Tagami, T; Gu, W X; Peairs, P T et al. (1998) A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol 12:1888-902
Tagami, T; Kopp, P; Johnson, W et al. (1998) The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors. Endocrinology 139:2535-44
Tagami, T; Jameson, J L (1998) Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone. Endocrinology 139:640-50

Showing the most recent 10 out of 33 publications